02.10.2014 Views

Drug-Resistant Malaria - libdoc.who.int - World Health Organization

Drug-Resistant Malaria - libdoc.who.int - World Health Organization

Drug-Resistant Malaria - libdoc.who.int - World Health Organization

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

RESEARCH FOR CONTROL / 81<br />

and Phase 1 and 2 clinical trials, enters the ultimate phases<br />

which are (ref. TRS.529):<br />

Phase 3: Pilot field trials in partially immune subjects<br />

Phase 4: Treatment of hospital patients<br />

Phase 5: Extended field trials<br />

Phase 6: Observations on mass drug administration<br />

While dose range-finding studies, and tolerability studies m<br />

different ethnic groups are essentially part of Phases 3 and 4,<br />

and the responsibility of specialized clinical workers, field<br />

research in drug development will be required with the release of<br />

a new preparation for Phase 5. Detai led protocols must be drawn<br />

up in close collaboration with investigators <strong>who</strong> have been<br />

responsible for the earlier phases of development, and, in the<br />

context of the present meeting, with the Secretariat of CHEMAL.<br />

PRIORITY TOPICS<br />

The following research topics<br />

priate for field or laboratory<br />

priority consideration.<br />

were<br />

based<br />

selected as being approresearch<br />

and deserving<br />

Effect of Gametocyt3cidal <strong>Drug</strong>s<br />

The effect of single doses of gametocytocidal drugs (e.g.<br />

primaquine) on the transmission of P. falciparum, including<br />

drug-resistant P.falciparum, as a complementary measure to vector<br />

control needs to~evaiuated.<br />

The place of gametocytocidal treatment in malaria control<br />

should be assessed 1n various epidemiological situations. This<br />

could be done in circumscribed populations which are sufficiently<br />

stable and accessible to allow adequate evaluation.<br />

When second-line drugs are being used (quinine or sulfadoxine/<br />

pyrimethamine or mefloquine) for the treatment of chloroquineresistant<br />

(or sulfadoxine/pyrimethamine-resistant) malaria, it<br />

becomes necessary to investigate whether the spread of these<br />

resistant strains will be restricted by the addition of primaquine<br />

to this regimen. Furthermore, it would be indicated to study the<br />

impact of the periodic (e.g. weekly) administration of primaquine<br />

on the spread of drug-resistant strains.<br />

Comparative Vector Competence for <strong>Resistant</strong> and<br />

Sensitive Parasite Strain~-----<br />

With regard to vector competence it has been suggested in the<br />

past that the transmission of chloroquine-resistant P.falciparum<br />

has been associated preferentially with one or more species of<br />

Anopheles. While there seems to be only questionable evidence to

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!